California Public Employees Retirement System
AIMT

California Public Employees Retirement System’s Aimmune Therapeutics AIMT Stock Holding History

California Public Employees Retirement System’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-96,400
Closed -$3.32M – 3637
2020
Q3 		$3.32M Sell
96,400
-6,563
-6% -$140K ﹤0.01% 1515
2020
Q2 		$1.72M Buy
102,963
+2,960
+3% +$50.3K ﹤0.01% 1881
2020
Q1 		$1.44M Sell
100,003
-800
-0.8% -$20.4K ﹤0.01% 1789
2019
Q4 		$3.37M Buy
100,803
+18,500
+22% +$517K ﹤0.01% 1719
2019
Q3 		$1.72M Buy
82,303
+31,362
+62% +$640K ﹤0.01% 1980
2019
Q2 		$1.06M Buy
50,941
+500
+1% +$10.3K ﹤0.01% 2122
2019
Q1 		$1.13M Sell
50,441
-1,200
-2% -$28.3K ﹤0.01% 2153
2018
Q4 		$1.24M Sell
51,641
-4,200
-8% -$109K ﹤0.01% 2061
2018
Q3 		$1.52M Sell
55,841
-2,614
-4% -$73.9K ﹤0.01% 2082
2018
Q2 		$1.57M Buy
58,455
+19,560
+50% +$599K ﹤0.01% 2054
2018
Q1 		$1.24M Buy
+38,895
New +$1.37M ﹤0.01% 2182

California Public Employees Retirement System's AIMT Position: Q4 2020 in Review

California Public Employees Retirement System sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 96,400 shares — an estimated $3.32M sold.

California Public Employees Retirement System first reported a position in AIMT in Q1 2018 and held it in 11 quarters. The position peaked at $3.37M in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • California Public Employees Retirement System reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • California Public Employees Retirement System sold 96,400 Aimmune Therapeutics shares in Q4 2020, an estimated $3.32M.
  • California Public Employees Retirement System first reported a position in Aimmune Therapeutics in Q1 2018 and held it in 11 quarters.
  • California Public Employees Retirement System's Aimmune Therapeutics position peaked at $3.37M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on California Public Employees Retirement System's 13F filing for Q4 2020, filed 2 Feb 2021.